Lv6
2904 积分 2025-04-28 加入
CD13 as a potential theranostic target for prostate-specific membrane antigen-negative prostate cancer and first-in-human study of [18F]AlF-CD13-L1 PET/CT imaging
23小时前
已完结
Mazdutide: First Approval
2天前
已完结
Tumor Uptake of the RGD Dimeric Probe 99mTc-G3-2P4-RGD2 is Correlated with Integrin αvβ3 Expressed on both Tumor Cells and Neovasculature
10天前
已完结
Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors
14天前
已完结
Pluvicto - A novel treatment for Prostate Cancer
15天前
已关闭
EVO756 is a novel MRGPRX2 antagonist that potently inhibits human mast cell degranulation in response to multiple agonists – potential treatment for CSU and beyond
4个月前
已关闭
Advances with the discovery and development of novel sigma 1 receptor antagonists for the management of pain
5个月前
已完结
The role of beta-catenin in cell adhesion, signal transduction, and cancer
5个月前
已完结
Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor
5个月前
已完结
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors – a review of patent literature from 2019–June 2023
6个月前
已完结
皖公网安备34019202002308
